NCT05490771

Clinical Trial Information

Trial Number: NCT05490771 (ClinicalTrials.gov)

Disease Type:

Hematopoietic Neoplasm/Lymphoma - Miscellaneous
Hematopoietic Neoplasm/Myeloma - Myeloma
Miscellaneous Neoplasm - Solid Tumor

Trial Title:

Phase II Study of Copanlisib in Patients With Tumors With PIK3CA Mutations (PTEN Loss Allowed)

Study ID:

EAY131-Z1F

Images are available?:

No

Is this a NCI-MATCH Trial?:

No

Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security

U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov

NIH…Turning Discovery Into Health^®